Concepedia

Stuart Bailey

SB

Statistics

Publications

10

Citations

704

H-Index

10

Active since

1999

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

Tris Pharma (United States)

University of California, Los Angeles

Dana-Farber Cancer Institute

Stuart Bailey is an author at Novartis (Switzerland) specializing in biostatistics, pharmacology, and public health.

Publications per year

1999–2023

10

Publications

10

Robust exchangeability designs for early phase clinical trials with multiple strata

Beat Neuenschwander, Simon Wandel, Satrajit Roychoudhury et al. · Pharmaceutical Statistics · 2015 · 172 citations

Public Health, Biostatistics, Epidemiologic Methods +12

First-in-Human Phase I Dose-Escalation Study of the HSP90 Inhibitor AUY922 in Patients with Advanced Solid Tumors

Cristiana Sessa, Geoffrey I. Shapiro, Kapil N. Bhalla et al. · Clinical Cancer Research · 2013 · 162 citations

Medicine, Oncology, Pharmacology +16

Stuart Bailey, Robert L. Grossman, H. Sivakumar et al. · 1999 · 83 citations · Full text

Engineering, Computer Engineering, Electrical Engineering +17

Machine learning for clinical trials in the era of COVID-19

William R. Zame, Ioana Bica, Cong Shen et al. · Statistics in Biopharmaceutical Research · 2020 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10

The management and mining of multiple predictive models using the predictive modeling markup language

Robert L. Grossman, Stuart Bailey, Avinash Ramu et al. · Information and Software Technology · 1999 · 66 citations

Computing, Computer Science, Data Science +14

1–5 of 10